Skip to main content
Premium Trial:

Request an Annual Quote

Theralink Acquires Immunotherapy Biomarker Patent From Vanderbilt University

NEW YORK – Theralink Technologies announced Monday that it acquired an exclusive license for methods related to predicting patient response to immunotherapies in cancer from Vanderbilt University.

The patent covers a method for detecting cell membrane expression of an MHC molecule in a human subject and then targeting that subject with an individually selected immunotherapeutic agent.

The newly acquired patent adds to Theralink's portfolio of licensed patents covering predictive biomarkers over a range of therapeutic classes.

Details of the licensing agreement were not disclosed.

"This patent has very broad and important claims that will immediately synergize with the commercially available Theralink Assay offered today," Mick Ruxin, CEO of Theralink, said in a statement. "This is one of the first of the so-called 'pan-tumor' predictive markers that Theralink will be utilizing: working not just for patients with breast cancer but for most solid tumor cancers."

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.